Lenskart IPO Day 2 Live Updates: ₹7,278 Crore Public Offer Sees Strong Demand Amid Rising GMP — Should You Subscribe?

Entering its second day of the IPO subscription today, November 3, 2025, following heavy investor participation on Day 1, the much-awaited public issue that opened for subscription on October 31 will close for bidding on November 4.

Backed by strong fundamentals and a growing omnichannel presence in India and in international markets, the IPO by the eyewear retailer has been greatly agitated for by both institutional and retail investors.

📈 Lenskart IPO GMP Today – Premium Continues to Soar

As of November 1, 2025 (3:54 PM), Lenskart Solutions Ltd’s shares were commanding a grey market premium (GMP) of ₹85 per share, according to market observers. Based on the upper price band of ₹402, this translates to an estimated listing price of around ₹487, implying a 21% premium over the issue price.

The strong GMP trend suggests bullish market sentiment ahead of the listing scheduled for November 10, 2025.

💡 Key IPO Details

Issue size: ₹7,278 crore

Price band: ₹382 – ₹402 per share

Valuation: ₹69,676 crore (at upper price band)

Bidding period: October 31 – November 4

Basis of allotment: November 6

Refunds and credit of shares: November 7

Listing date: November 10

Anchor investors subscribed on October 30, indicating strong early confidence in the issue.

🏢 Why Investors Are Bullish on Lenskart

1. Centralised Supply Chain & Automation:

Lenskart’s AI-driven manufacturing and logistics system enables cost efficiency, faster delivery, and consistent product quality.

2. In-house Innovation:

With its own production and design facilities, Lenskart ensures rapid product launches and tight quality control.

3. Direct-to-Consumer Model:

The company’s D2C approach eliminates middlemen, keeping prices competitive and customer service efficient.

4. Omnichannel Strength:

Lenskart’s integration of online and offline platforms through advanced technology enhances customer reach and satisfaction.

⚠️ Risks to Watch

Supply Chain Dependence on China:

Lenskart sources certain frames and raw materials from China via its joint venture Baofeng Framekart Technology Ltd. Any disruption in supply could affect operations.

Legal Proceedings:

Ongoing legal cases involving the company, its directors, and subsidiaries could pose risks if outcomes are unfavourable.

💭 Should You Subscribe?

According to different market analysts, the IPO turns out to be an attractive long-term bet because of a strong GMP, proven profitability, and being a brand leader. However, potential investors should consider China exposure and legal uncertainties before making their final decision.